Showing 1-5 of 12 news & articles:
Big Data Analyses of the New ACC/AHA Blood Pressure Guidelines

77% OF ADULT PATIENTS, SEEN BY HEALTHCARE PROVIDERS, NOW HAVE HIGH BLOOD PRESSURE OM1 releases big data analyses of impact of new blood pressure guidelines BOSTON, November 20, 2017 — OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced the release of big data[…]

OM1 Named to CIOReview Top 100 Big Data Providers 2017

BOSTON, August 22, 2017 — OM1 has been recognized by CIOReview Magazine as one of the top 100 most promising big data solution providers in 2017. OM1 was nominated and ultimately selected following CIOReview’s annual comprehensive review process. CIOReview’s editorial team analyzed approximately 1,000 companies that provide big data solutions and are at the forefront[…]

Big Ideas for Big Data Analytics in Real-World Evidence

Published August 9  – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]

ICPE Annual – Montreal

On August 28-30, we will be at ICPE 2017 in Montreal. We hope to see you there: Meet with our experts Dr. Richard Gliklich and Kathryn Starzyk Take our survey on Big Data and RWE View our poster “Testing the Robustness of the Outcome Measures Framework” Visit our booth and grab your OM1 goodies and[…]

Current and Future Use of HEOR Data in Decision Making

Published by PM360 – August 9, 2017 The growing power of payers in healthcare decision-making has put an increased emphasis on health economics and outcomes research (HEOR), as the data collected through that research is key to demonstrating the value of your drug. As HEOR teams have grown in importance, their roles have expanded to[…]